VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 601–700 of 1,013
Endothelial RAF1/ERK activation regulates arterial morphogenesis
Deng, Y., Larrivée, B., Zhuang, Z. W., Atri, D. S., Moraes, F., Prahst, C., Eichmann, A., & Simons, M. (2013) · Blood · doi:10.1182/blood-2012-12-474601 · Cited by 76
Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis
Huang, W., Nagahashi, M., Terracina, K. P., & Takabe, K. (2013) · Biomolecules · doi:10.3390/biom3030408 · Cited by 75
“Typical signaling from VEGFRs promote cell survival, proliferation, and migration [14].”
BackgroundCuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression
Song, H., Wang, W., Zhao, P., Qi, Z., & Zhao, S. (2013) · Nanoscale · doi:10.1039/c3nr04363k · Cited by 72
Falk, T., Zhang, S., & Sherman, S. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-49 · Cited by 70
“VEGFR1 signaling has been previously linked to the induction of MMP9 in lung endothelial cells [28] suggesting a potential role of MMP9 in the effects of VEGF-B that should be further investigated.”
InfluentialTsai, A.-C., Pan, S., Liao, C.-H., Guh, J., Wang, S., Sun, H., Liu, Y.-N., Chen, C.-C., Shen, C.-C., Chang, Y.-L., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.11.020 · Cited by 72
MicroRNA Control of Vascular Endothelial Growth Factor Signaling Output During Vascular Development
Dang, L. T. H., Lawson, N. D., & Fish, J. E. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300142 · Cited by 75
“Upon binding to its receptor tyrosine kinase, Vegfr-2, Vegfa can elicit distinct responses, including proliferation, cell survival, permeability, differentiation, and migration.(9) These effects are mediated through the activation of several downstream signaling effectors.”
InfluentialSun, J. T., Yang, K., Lu, L., Zhu, Z. B., Zhu, J. Z., Ni, J., Han, H., Chen, N., & Zhang, R. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2015 · Cited by 72
“As a primary receptor of VEGF, VEGFR2 mediates endothelial migration and proliferation after vascular injury (29).”
BackgroundInfluentialOganesian, A., Armstrong, L. C., Migliorini, M. M., Strickland, D. K., & BORNSTEIN, P. K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0649 · Cited by 72
“It has been shown that both phosphatidyl inositol-3 kinase (PI3K) and the PI3K-dependent serine-threonine kinase, Akt, can be activated in ECs by VEGF (Olsson et al., 2006).”
BackgroundEndoglin interacts with VEGFR2 to promote angiogenesis
Tian, H., Huang, J. J., Golzio, C., Gao, X., Hector-Greene, M., Katsanis, N., & Blobe, G. C. (2018) · The FASEB Journal · doi:10.1096/fj.201700867rr · Cited by 77
“As VEGFR2 has multiple phosphorylation sites mediating different downstream pathways (28), we examined endoglin’s role in VEGFR2 phosphorylation at different sites.”
BackgroundAbdallah, A. E., Eissa, S. I., Ward, M. M. S. A., Mabrouk, R. R., Mehany, A. B. M., & El‐Zahabi, M. A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104695 · Cited by 71
Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 68
“The VEGF receptor regulates the Ras–Raf–MEK pathway (which promotes endothelial cell proliferation), the PI3K–AKT system (which promotes endothelial cell survival), and the p38 MAPK–HSP27 route (which promotes endothelial cell migration) [36].”
BackgroundZhao, D., Qin, C., Fan, X., Li, Y. C., & Gu, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.069 · Cited by 74
Kurogane, Y., Miyata, M., Kubo, Y., Nagamatsu, Y., Kundu, R. K., Uemura, A., Ishida, T., Quertermous, T., Hirata, K., & Rikitake, Y. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244004 · Cited by 75
“Akt, extracellular signal–regulated kinase (ERK), and the Rho family small G proteins.(1) The Rho family consists of”
BackgroundMechanistic insight into activation of MAPK signaling by pro-angiogenic factors
Song, M., & Finley, S. D. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0668-5 · Cited by 69
Su, J. L.-S., Satchell, S. C., Wertheim, J. A., & Shah, R. N. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.02.001 · Cited by 75
“VEGF signaling is important in a variety of physiological contexts, but it is especially critical in the development of new blood vessels and maintenance of healthy vasculature and endothelial function[20].”
BackgroundSingle-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases
Bélanger, K., Iqbal, U. H., Tanha, J., MacKenzie, R., Moreno, M., & Stanimirovic, D. B. (2019) · Antibodies · doi:10.3390/antib8020027 · Cited by 75
“These include vascular endothelial growth factor receptor 2 (VEGFR2) [139], endothelial cell adhesion molecules (αvβ3 and αvβ5 integrins) [140], and insulin-like growth factor binding protein 7 (IGFBP7) [141,142].”
BackgroundMechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
Beckmann, R., Houben, A., Tohidnezhad, M., Kweider, N., Fragoulis, A., Wruck, C. J., Brandenburg, L. O., Hermanns‐Sachweh, B., Goldring, M. B., Pufe, T., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915456 · Cited by 71
“Whether these apparently opposing effects of VEGFR1 on VEGFR2 activity are strain-dependent and involved in chondrocyte differentiation at all also remains to be investigated.”
BackgroundInfluentialThe Angiopoietin-Tie2 Pathway in Critical Illness
Sack, K. D., Kellum, J. A., & Parikh, S. M. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.12.003 · Cited by 77
Sunitinib resistance in renal cell carcinoma
Morais, C. (2014) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2014.7 · Cited by 75
Jarray, R., Allain, B., Borriello, L., Biard, D. S. F., Loukaci, A., Larghero, J., Hadj-Slimane, R., Garbay, C., Lepelletier, Y., & Raynaud, F. (2011) · Biochimie · doi:10.1016/j.biochi.2011.07.010 · Cited by 70
Luan, X., Gao, C., Zhang, N., Chen, Y., Sun, Q., Tan, C., Liu, H., Jin, Y., & Jiang, Y. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.053 · Cited by 74
Lenertz, L. Y., Gavala, M. L., Zhu, Y., & Bertics, P. J. (2011) · Immunologic Research · doi:10.1007/s12026-011-8203-4 · Cited by 66
“One immune factor that has recently been shown to be regulated at the mRNA level in response to P2X7 signaling is VEGF, which is a pro-angiogenic factor and a drug target for multiple types of cancer [21, 105].”
BackgroundJan, S. L., Hayashi, M., Kasza, Z., Eriksson, I., Bishop, J. R., Weibrecht, I., Heldin, J., Holmborn, K., Jakobsson, L., Söderberg, O., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240622 · Cited by 70
“Abramsson and coworkers have previously shown that PDGFB signaling in these cells, expressing normal levels of CS, is reduced due to reduced levels of functional HS.9 Using the Ndst12/2 MEF model, we could show that PDGFB signaling could be further reduced by degradation of CS by CSase treatment (Figure 4G and Figure…”
BackgroundSelf-citationKim, W., & Lee, H. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07177.x · Cited by 72
Plasmalemma Vesicle–Associated Protein Has a Key Role in Blood-Retinal Barrier Loss
Wisniewska‐Kruk, J., van der Wijk, A., van Veen, H. A., Gorgels, T. G. M. F., Vogels, I. M. C., Versteeg, D., Noorden, C. J. F. V., Schlingemann, R. O., & Klaassen, I. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.019 · Cited by 73
VEGFR1 and VEGFR2 in Alzheimer’s Disease
Harris, R., Miners, J. S., Allen, S. J., & Love, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170745 · Cited by 72
“VEGFR2 was first iden-tified as a major regulator of angiogenesis [48] and is now known to mediate endothelial cell proliferation, migration, permeability, and survival [49–51].”
Antony, J., Thiery, J. P., & Huang, R. Y. (2019) · Physical Biology · doi:10.1088/1478-3975/ab157a · Cited by 73
Bone marrow niche in the myelodysplastic syndromes
Cogle, C. R., Saki, N., Khodadi, E., Li, J., Shahjahani, M., & Azizidoost, S. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.06.017 · Cited by 73
The role of the insulin-like growth factor-I receptor in malignancy: An update
Seccareccia, E., & Brodt, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.09.003 · Cited by 75
“Its activity is regulated by hypoxia inducible factors (HIF) that translocate to the nucleus in response to reduced oxygen levels and activate the expression of VEGF-A – themajor pro-angiogenic factor (for a review on the VEGF family of growth factors, please see [57,58]).”
BackgroundMonaghan, R. M., Page, D. J., Østergaard, P., & Keavney, B. D. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa291 · Cited by 74
“throughout life in the circulatory system but also in other tissues (Figure 1).(16,17) VEGFRs all homodimerize; in addition, VEGFR2 can heter-”
BackgroundOld Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer
Ntellas, P., Mavroeidis, L., Gκoura, S., Gazouli, I., Amylidi, A.-L., Papadaki, A., Zarkavelis, G., Mauri, D., Karpathiou, G., Kolettas, E., et al. (2020) · Cancers · doi:10.3390/cancers12113145 · Cited by 76
“These interactions can influence VEGFR mediated responses, for example, by affecting the half-life of the receptor complex or VEGFR phosphorylation [26,27].”
BackgroundInfluentialZou, L., Liu, X., Li, J., Li, W., Zhang, L., Fu, C., Zhang, J., & Gu, Z. (2021) · Theranostics · doi:10.7150/thno.42260 · Cited by 70
Chronic and non-healing wounds: The story of vascular endothelial growth factor
Zhou, K., Ma, Y., & Brogan, M. S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.06.017 · Cited by 69
“Effects of VEGF are mediated through binding of its subtypes to tyrosine kinase receptors (the VEGFRs) on the cell surface, causing them to dimerize and become activated through transphosphorylation [7–9].”
BackgroundInfluentialToll-Like Receptors in Angiogenesis
Grote, K., Schütt, H., & Schieffer, B. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.92 · Cited by 77
“Vascular endothelial growth factor (VEGF) – which was initially described to modify endothelial cell permeability[20] – and its receptor (VEGFR) are a predominant factor and were intensively studied in the last 2 decades[21].”
BackgroundPathological roles of the VEGF/SphK pathway in Niemann–Pick type C neurons
Lee, H., Lee, J. K., Park, M. H., Hong, Y. R., Marti, H. H., Kim, H., Okada, Y., Otsu, M., Seo, E.-J., Park, J.-H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6514 · Cited by 69
Control of neuronal migration through rostral migration stream in mice
Sun, W., Kim, H., & Moon, Y. (2010) · Anatomy & Cell Biology · doi:10.5115/acb.2010.43.4.269 · Cited by 63
“VEGF is a major regulator of vasculogenesis and angiogenesis (Olsson et al., 2006).”
BackgroundLee, S., Jeong, H.-K., Lee, J., Yang, J., Lee, E. J., Kim, S., Youn, S., Lee, J., Kim, W. J., Kim, K., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101107 · Cited by 70
“E), because VEGF is a well-established endothelial growth and differentiation factor (Olsson et al, 2006).”
Tuck, M. L., Dluhy, R. G., & Williams, G. H. (1975) · PubMed · Cited by 76
Li, P., Chen, J., Wang, J., Zhou, W., Wang, X., Li, B., Tao, W., Wang, W., Wang, Y., & Yang, L. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.07.001 · Cited by 70
Silk Fibroin As an Immobilization Matrix for Sensing Applications
Prakash, N. J., Mane, P. P., George, S. M., & Kandasubramanian, B. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00080 · Cited by 70
Tossetta, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112893 · Cited by 73
“Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and vasculogenesis that binds to the tyrosine kinase receptors (VEGFRs) on endothelial cells [62].”
BackgroundFBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation
Wang, R., Wang, Y., Liu, N., Ren, C., Jiang, C., Zhang, K., Yu, S., Chen, Y., Tang, H., Deng, Q., et al. (2013) · Cell Research · doi:10.1038/cr.2013.42 · Cited by 68
Gruenwald, V., Beutel, G., Schuch-Jantsch, S., Reuter, C. W., Ivanyi, P., Ganser, A., & Haubitz, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-695 · Cited by 68
“The biological relevance of the different VEGFR family members in this process was elucidated in murine models, and VEGFR-2 was determined to be the main regulator of neo-angiogenesis and the most promising target for therapeutic intervention [3].”
BackgroundSiegfried, J. M., Gubish, C. T., Rothstein, M. E., Henry, C. L., & Stabile, L. P. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824177ea · Cited by 68
Bellou, S., Hink, M. A., Bagli, E., Panopoulou, E., Bastiaens, P. I. H., Murphy, C., & Fotsis, T. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00058.2009 · Cited by 68
Cesca, F., Yabe, A., Spencer‐Dene, B., Scholz‐Starke, J., Medrihan, L., Maden, C. H., Gerhardt, H., Orriss, I. R., Baldelli, P., AlQatari, M., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.141 · Cited by 72
Ragunathrao, V. A. B., Anwar, M., Akhter, M. Z., Chavez, A., Mao, D. Y., Natarajan, V., Lakshmikanthan, S., Chrzanowska‐Wodnicka, M., Dudek, A. Z., Claesson, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.036 · Cited by 70
“In this regard, activation of the small GTPase Rac1 induces EC migration downstream of VEGFR2 signaling, while phosphorylation of extracellular signal regulated kinase1/2 (ERK1/2) mediates proliferation and survival of ECs, respectively (Claesson-Welsh and Welsh, 2013; Matsumoto and Claesson-Welsh, 2001; Olsson et al.…”
BackgroundChang, Y., Chang, M., Wei, S., Tien, Y., Hsu, C., Liang, P., Tsao, P., Jan, I., & Wong, J. (2008) · Pancreas · doi:10.1097/mpa.0b013e318164548a · Cited by 68
Hsu, M.-C., Pan, M.-R., & Hung, W.-C. (2019) · Cells · doi:10.3390/cells8030270 · Cited by 67
Extracellular matrix in angiogenesis: dynamic structures with translational potential
Eming, S. A., & Hubbell, J. A. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01309.x · Cited by 66
Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
Bender, R. J., & Gabhann, F. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061788 · Cited by 72
“VEGFR2 signaling plays a prominent role in promoting angiogenesis, while VEGFR3 signaling promotes lymphangiogenesis [1,2,3].”
BackgroundVEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling
Zhang, J., Silva, T., Yarovinsky, T. O., Manes, T. D., Tavakoli, S., Nie, L., Tellides, G., Pober, J. S., Bender, J. R., & Sadeghi, M. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.210963 · Cited by 67
The role of mitochondria in angiogenesis
Reichard, A., & Asosingh, K. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4488-x · Cited by 69
Gao, P., Shen, F., Gabriel, R. A., Law, D., Yang, E. Y., Yang, G.-Y., Young, W. L., & Su, H. (2009) · Stroke · doi:10.1161/strokeaha.109.561050 · Cited by 66
“Discussion In the present study, we demonstrated that: (1) AAV1mediated overexpression of VEGF in the normal adult mouse brain induced angiogenesis and neurogenesis; (2) the angiogenic and neurogenic responses to VEGF stimulation in the brain of 24-month-old mice were attenuated; and (3) overexpression of VEGF upregul…”
BackgroundThe role of extracellular matrix in angiogenesis: Beyond adhesion and structure
Libby, J. R., Royce, H. A., Walker, S. R., & Li, L. (2024) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2024.100097 · Cited by 97
“Although many GFs (e.g., basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β )), are involved in this process, vascular endothelial growth factor-A (VEGF-A) is the master modulator of angiogenesis [31,32].”
BackgroundTargeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
Xu, W., Li, B., Lam, A. K.-Y., Tsao, S. W., Law, S. Y., Chan, K. W., Yuan, Q. J., & Cheung, A. L. (2014) · Oncotarget · doi:10.18632/oncotarget.2781 · Cited by 66
“It is widely accepted that VEGFR2 mediates most of the cellular responses to VEGF [29], while the downstream signaling of VEGFR1 is less well defined.”
Guidolin, D., Albertin, G., Spinazzi, R., Sorato, E., Mascarin, A., Cavallo, D., Antonello, M., & Ribatti, D. (2008) · Peptides · doi:10.1016/j.peptides.2008.07.009 · Cited by 68
“[33] Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L.”
InfluentialExpression of VEGF Receptors on Endothelial Cells in Mouse Skeletal Muscle
Imoukhuede, P. I., & Popel, A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044791 · Cited by 72
“This VEGFR1 migratory function is also observed in macrophages [69,70], monocytes [71,72,73], and endothelial cells [74].”
BackgroundBiomarkers for Anti-Angiogenic Therapy in Cancer
Wehland, M., Bauer, J. W., Magnusson, N. E., Infanger, M., & Grimm, D. G. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059338 · Cited by 74
Therapeutic Targets in Malignant Glioblastoma Microenvironment
Barcellos‐Hoff, M. H., Newcomb, E. W., Zagzag, D., & Narayana, A. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2009.02.004 · Cited by 66
Yao, L., Testini, C., Tvorogov, D., Anisimov, A., Vargas, S. O., Bałuk, P., Pytowski, B., Claesson, L., Alitalo, K. K., & McDonald, D. M. (2014) · Circulation Research · doi:10.1161/circresaha.114.303119 · Cited by 66
Breen, M. E., & Soellner, M. B. (2014) · ACS Chemical Biology · doi:10.1021/cb5008376 · Cited by 66
The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling
Jopling, H. M., Howell, G. J., Gamper, N. L., & Ponnambalam, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.093 · Cited by 73
VEGF Receptor Tyrosine Kinases
Álvarez-Aznar, A., Muhl, L., & Gaengel, K. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.001 · Cited by 75
Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan
Yu, Y., Chen, R., Sun, Y., Pan, Y., Tang, W., Zhang, S., Cao, L., Yuan, Y., Wang, J., & Liu, C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.02.031 · Cited by 67
Changes in cerebral autoregulation and blood biomarkers after remote ischemic preconditioning
Guo, Z.-N., Guo, W.-T., Liu, J., Chang, J., Ma, H., Zhang, P., Zhang, F.-L., Han, K., Hu, H., Jin, H., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007732 · Cited by 74
Tumor progression-dependent angiogenesis in gastric cancer and its potential application
Hsieh, H., & Tsai, M.-M. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i9.686 · Cited by 68
Li, X., Shen, Y., Ichikawa, H., Antes, T. J., & Goldberg, G. S. (2009) · Oncogene · doi:10.1038/onc.2009.278 · Cited by 66
“However, although our analysis did not identify vascular endothelial growth factor A as a prime target of miR-126, our data indicate that Src induces the expression of its receptor, Vefgr2 (Olsson et al., 2006).”
ResultPan, X., Yuan, S., Xun, X., Fan, Z., Xue, X., Zhang, C., Wang, J., & Deng, J. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101661 · Cited by 66
Chappell, J. C., & Bautch, V. L. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)90002-1 · Cited by 73
“The VEGF pathway is a vital regulator of vascular development and has been the subject of several comprehensive reviews (Ferrara et al., 2003; Olsson et al., 2006).”
BackgroundEndothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling
Awasthi, N., Schwarz, M. A., Verma, V. K., Cappiello, C. D., & Schwarz, R. E. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.106 · Cited by 65
“17 Several studies have shown that VEGF induces proliferation of ECs”
BackgroundVascular endothelial growth factor activates the Tie family of receptor tyrosine kinases
Singh, H., Milner, C. S., Aguilar-Hernández, M., Patel, N. R., & Brindle, N. P. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.04.002 · Cited by 65
Volz, A., Huber, B., & Kluger, P. J. (2016) · Differentiation · doi:10.1016/j.diff.2016.02.003 · Cited by 77
Parthiban, S. P., Rana, D., Jabbari, E., Benkirane-Jessel, N., & Ramalingam, M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.046 · Cited by 66
Mesquita, J., Sousa, J. P. C., Vaz-Pereira, S., Neves, A., Passarinha, L. A., & Tomaz, C. T. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.11.005 · Cited by 69
Endothelial α3β1-Integrin Represses Pathological Angiogenesis and Sustains Endothelial-VEGF
da Silva, R. G., Tavora, B., Robinson, S. D., Reynolds, L. E., Szekeres, C. K., Lamar, J. M., Batista, S., Kostourou, V., Germain, M., Reynolds, A. R., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100043 · Cited by 65
Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells
Shin, J.-Y., Yoon, I., Kim, J.-S., Kim, B., & Park, C. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.006 · Cited by 65
“Vascular endothelial growth factor (VEGF) plays a key role in physiological and pathological angiogenesis including the regulation of vascular development during embryogenesis and tumor-related neovascularization [1,2].”
BackgroundDarwish, I., & Liles, W. C. (2013) · Virulence · doi:10.4161/viru.25740 · Cited by 68
“VEGF is a well-established regulator of vascular permeability and exerts its effects through binding endothelial cell-specific membrane tyrosine kinase receptors, VEGFR1–3.10 Upon activation by its cognate ligand, VEGFR2 www.landesbioscience.com virulence 573 Special FocuS Review Special FocuS Review VEGFR2 antibody d…”
BackgroundInfluentialLeone, P., Lernia, G. D., Solimando, A. G., Cicco, S., Saltarella, I., Lamanuzzi, A., Ria, R., Frassanito, M. A., Ponzoni, M., Ditonno, P., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1486949 · Cited by 66
“of vascular EC, and both are associated with tumor neoangiogenesis.(35-39) NY-ESO-1157–165 HLA-A*0201 PE-conjugated pentamer was purchased from Proimmune and used according to the vendor’s instructions.”
MethodThe Emerging Role of Voltage-Gated Sodium Channels in Tumor Biology
Mao, W., Zhang, J., Körner, H., Jiang, Y., & Ying, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00124 · Cited by 66
“Furthermore, vascular endothelial growth factor (VEGF) can promote angiogenesis that plays an important role in the process of tumor cell invasion (55).”
BackgroundAnti‐VEGF DNA‐based aptamers in cancer therapeutics and diagnostics
Riccardi, C., Napolitano, E., Platella, C., Musumeci, D., Melone, M. A. B., & Montesarchio, D. (2020) · Medicinal Research Reviews · doi:10.1002/med.21737 · Cited by 67
Claridge, S., Raeppel, F., Granger, M., Bernstein, N., Saavedra, O. M., Zhan, L., Llewellyn, D. B., Wahhab, A., Déziel, R., Rahil, J. F., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.009 · Cited by 64
The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth
Zhu, H., Carpenter, R. L., Han, W., & Lo, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.014 · Cited by 70
“We next investigated the role of VEGF-A in TGLI1-mediated GBM angiogenesis because VEGF-A is the ligand of VEGFR1/2 and the binding to the receptors activates vascular proliferation [29, 30].”
BackgroundAntiangiogenic and anticancer molecules in cartilage
Patra, D., & Sandell, L. J. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.3 · Cited by 69
Shikatani, E. A., Trifonova, A., Mandel, E. R., Liu, S. T. K., Roudier, E. A., Крылова, А. К., Szigiato, A.-A., Beaudry, J. L., Riddell, M. C., & Haas, T. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046625 · Cited by 73
“VEGF is a potent pro-angiogenic factor that promotes the activation of multiple signal pathways, including MAPK and Akt, leading to increased proliferation, migration and survival of endothelial cells [43].”
BackgroundGremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway
Lavoz, C., Alique, M., Rodrigues‐Díez, R., Pató, J., Kéri, G., Mezzano, S. A., Egido, J., & Ruiz‐Ortega, M. (2015) · The Journal of Pathology · doi:10.1002/path.4537 · Cited by 64
“One of the earliest steps in VEGFR2 activation is auto-phosphorylation on tyrosine residues [14].”
BackgroundInfluentialEmerging roles of post‐translational modifications in signal transduction and angiogenesis
Rahimi, N., & Costello, C. E. (2015) · PROTEOMICS · doi:10.1002/pmic.201400183 · Cited by 63
Stanley, E., Johnston, D. S., Fan, J., Papadopoulos, V., Chen, H., Ge, R., Zirkin, B. R., & Jelinsky, S. A. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.091850 · Cited by 64
Park, S. I., Shah, A. N., Zhang, J., & Gallick, G. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1207 · Cited by 70
“Collectively, these data suggest that individual VEGF receptors mediate different, but overlapping biologic functions, and also that VEGFRs exert their functions by interacting with other signaling molecules [35,36] .”
BackgroundTransmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis
Nie, L., Guo, X., Esmailzadeh, L., Zhang, J., Asadi, A., Collinge, M., Li, X., Kim, J., Woolls, M. J., Jin, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67752 · Cited by 71
“VEGF-induced Akt and p44/42 MAPK activation supports EC survival and proliferation, whereas p38 MAPK phosphorylation mediates actin reorganization and cell migration (20). eNOS phosphorylation, which mediates many VEGF functions, is similarly Akt dependent (20).”
InfluentialRowson-Hodel, A. R., Wald, J. H., Hatakeyama, J., O’Neal, W. K., Stonebraker, J. R., VanderVorst, K., Saldana, M., Borowsky, A. D., Sweeney, C. A., & Carraway, K. L. (2017) · Oncogene · doi:10.1038/onc.2017.327 · Cited by 65
FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
Li, X., Gao, Y., Li, J., Zhang, K., Han, J., Li, W., Hao, Q., Zhang, W., Wang, S., Zeng, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0790-8 · Cited by 64
Salem, M. G., El-Maaty, D. M. A., El-Deen, Y. I. M., Elesawy, B. H., Askary, A. E., Saleh, A., Saied, E. M., & Behery, M. E. (2022) · Molecules · doi:10.3390/molecules27154898 · Cited by 65
A review on biomaterials-based scaffold: An emerging tool for bone tissue engineering
Francis, A. P., Augustus, A. R., Chandramohan, S., Bhat, S. A., Priya, V. V., & Rajagopalan, R. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.105124 · Cited by 73
Smith, G. A., Fearnley, G. W., Tomlinson, D. C., Harrison, M. A., & Ponnambalam, S. (2015) · Bioscience Reports · doi:10.1042/bsr20150171 · Cited by 69
Cui, H., Wang, Y., Huang, H., Yu, W., Bai, M., Zhang, L., Bryan, B. A., Wang, Y., Luo, J., Li, D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571000 · Cited by 63
“VEGF proteins stimulate cellular responses by binding to their tyrosine kinase receptors, known as VEGF receptors (VEGFR1–3) (6).”
BackgroundInfluentialHashimoto, A., Hashimoto, S., Andõ, R., Noda, K., Ogawa, E., Kotani, H., Hirose, M., Menju, T., Morishige, M., Manabe, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023359 · Cited by 67
“Although signaling pathways downstream of VEGFR2 have been extensively studied [21], none of them could interpret the”
BackgroundInfluentialFröhlich, C., Klitgaard, M. C., Noer, J. B., Kotzsch, A., Nehammer, C., Kronqvist, P., Berthelsen, J., Blobel, C., Kveiborg, M., Albrechtsen, R., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121558 · Cited by 66
Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway
Liao, X., Zhou, X., Mak, N. K., & Leung, K. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082294 · Cited by 63
“Vascular endothelial growth factor receptor 2 (VEGFR2) is the primary receptor of VEGF and the major mediator of VEGF-induced proangiogenesis signalling in endothelial cells [6,7].”
BackgroundSinha, S., Vohra, P. K., Bhattacharya, R., Dutta, S. K., Sinha, S., & Mukhopadhyay, D. (2009) · Journal of Cell Science · doi:10.1242/jcs.053124 · Cited by 64
“The binding of VEGF to its receptors induces dimerization and subsequent receptor phosphorylation, which then leads to the activation of several intracellular downstream signaling pathways promoting angiogenesis (Olsson et al., 2006; Sakurai et al., 2005; Takahashi et al., 2001; Zachary, 2003).”
Background
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.